All Stories

  1. Machine learning-assisted resting-state electroencephalography improves diagnostic accuracy in psychiatric disorders: A narrative review

    Article • Advanced Technology in Neuroscience, January 2026, Wolters Kluwer Health

    Dr Madia Lozupone

  2. Gustatory dysfunction and oral frailty: Emerging implications for Alzheimer's disease

    Article • Journal of Alzheimer’s Disease, November 2025, SAGE Publications

    Dr Madia Lozupone

  3. Associations among self-reported oral health and intrinsic capacity domains in U.S. older adults: analysis from NHANES 2009–2014

    Article • Clinical Oral Investigations, October 2025, Springer Science + Business Media

    Dr Madia Lozupone

  4. Association between periodontal disease and intrinsic capacity in older adults: insights from NHANES 2009–2014

    Article • GeroScience, September 2025, Springer Science + Business Media

    Dr Madia Lozupone

  5. The therapeutic potential of thalassotherapy for enhancing well-being and reducing pharmaceutical costs in individuals with disabilities

    Article • Frontiers in Psychology, September 2025, Frontiers

    Dr Madia Lozupone

  6. Novel approaches for the treatment of frontotemporal dementia: is there hope for the future?

    Article • Expert Review of Neurotherapeutics, August 2025, Taylor & Francis

    Dr Madia Lozupone

  7. Alzheimer's Disease May Benefit from Olive Oil Polyphenols: A Systematic Review on Preclinical Evidence Supporting the Effect of Oleocanthal on Amyloid-β Load

    Article • Current Neuropharmacology, August 2025, Bentham Science Publishers

    Dr Madia Lozupone

  8. Corrigendum to “Can ketamine therapy overcome treatment-resistant depression in Alzheimer's disease and older adults? Preclinical and clinical evidence” [Biomed. Pharmacother. 188 (2025) 118199]

    Article • Biomedicine & Pharmacotherapy, August 2025, Elsevier

    Dr Madia Lozupone

  9. Targeting oral frailty indicators of late-life cognitive disorders and depression: a systematic review

    Article • Age and Ageing, July 2025, Oxford University Press (OUP)

    Dr Madia Lozupone

  10. Uncertainties in anti-amyloid monoclonal antibody therapy for Alzheimer’s disease: the challenges ahead

    Article • Expert Review of Neurotherapeutics, May 2025, Taylor & Francis

    Dr Madia Lozupone

  11. The Effect of a Mediterranean Diet on Arterial Stiffness: A Systematic Review

    Article • Nutrients, March 2025, MDPI AG

    Dr Giuseppe Lisco, Dr Madia Lozupone

  12. An update on emerging anti-amyloid-β monoclonal antibodies for treating Alzheimer’s disease: the role of apolipoprotein E

    Article • Expert Opinion on Emerging Drugs, March 2025, Taylor & Francis

    Dr Madia Lozupone

  13. Neuropsychiatric symptoms and apolipoprotein E genotypes in neurocognitive disorders

    Article • Neural Regeneration Research, March 2025, Wolters Kluwer Health

    Dr Madia Lozupone

  14. The Biological Rationale for Integrating Intrinsic Capacity Into Frailty Models

    Article • Clinical Interventions in Aging, March 2025, Taylor & Francis

    Dr Madia Lozupone

  15. Successes and failures: the latest advances in the clinical development of amyloid–β–targeting monoclonal antibodies for treating Alzheimer's disease

    Article • Expert Opinion on Biological Therapy, February 2025, Taylor & Francis

    Dr Madia Lozupone

  16. Oral frailty indicators and cardio- and cerebrovascular diseases in older age: A systematic review

    Article • Mechanisms of Ageing and Development, February 2025, Elsevier

    Dr Madia Lozupone

  17. Psychiatry and sensation: the epigenetic links

    Article • Epigenomics, October 2024, Taylor & Francis

    Dr Madia Lozupone

  18. Association of Loneliness with Functional and Cognitive Status in Minor and Major Neurocognitive Disorders

    Article • Life, September 2024, MDPI AG

    Dr Madia Lozupone

  19. Association of Loneliness with Functional and Cognitive Status in Minor and Major Neurocognitive Disorders

    Article • September 2024, MDPI AG

    Dr Madia Lozupone

  20. Oral health indicators and bone mineral density disorders in older age: A systematic review

    Article • Ageing Research Reviews, September 2024, Elsevier

    Dr Madia Lozupone, Professor Daniele Manfredini

  21. Dietary Intake of Polyphenols and All-Cause Mortality: A Systematic Review with Meta-Analysis

    Article • Metabolites, July 2024, MDPI AG

    Dr Giuseppe Lisco, Dr Madia Lozupone

  22. Social Dysfunction and Apathy: Transdiagnostic Domains in Late-Life Cognitive Disorders

    Article • Journal of Alzheimer’s Disease, July 2024, IOS Press

    Dr Madia Lozupone

  23. Impact of periodontal disease on cognitive disorders, dementia, and depression: a systematic review and meta-analysis

    Article • GeroScience, June 2024, Springer Science + Business Media

    Dr Madia Lozupone

  24. Lessons learned from the failure of solanezumab as a prospective treatment strategy for Alzheimer’s disease

    Article • Expert Opinion on Drug Discovery, April 2024, Taylor & Francis

    Dr Madia Lozupone

  25. How can we manage progressive supranuclear palsy syndrome with pharmacotherapy?

    Article • Expert Opinion on Pharmacotherapy, March 2024, Taylor & Francis

    Dr Madia Lozupone

  26. Multidimensional complex frailty phenotypes: epidemiological impact of oral frailty in older age

    Article • European Geriatric Medicine, February 2024, Springer Science + Business Media

    Dr Madia Lozupone

  27. Correction to: Ultra‑processed food consumption and nutritional frailty in older age

    Article • GeroScience, February 2024, Springer Science + Business Media

    Dr Madia Lozupone

  28. Depressive and Biopsychosocial Frailty Phenotypes: Impact on Late-life Cognitive Disorders

    Article • February 2024, IOS Press

    Dr Madia Lozupone

  29. The epigenetics of frailty

    Article • Epigenomics, December 2023, Taylor & Francis

    Dr Madia Lozupone

  30. The Impact of Apolipoprotein E (APOE) Epigenetics on Aging and Sporadic Alzheimer’s Disease

    Article • Biology, December 2023, MDPI AG

    Dr Madia Lozupone

  31. The Impact of Apolipoprotein E (APOE) Epigenetics on Aging and Sporadic Alzheimer’s Disease

    Article • November 2023, MDPI AG

    Dr Madia Lozupone

  32. Nutritional patterns as machine learning predictors of liver health in a population of elderly subjects

    Article • Nutrition Metabolism and Cardiovascular Diseases, November 2023, Elsevier

    Dr Madia Lozupone

  33. The Relationship between Oral Health-Related Quality of Life and Body Mass Index in an Older Population from Southern Italy: The Salus in Apulia Study

    Article • Journal of Personalized Medicine, August 2023, MDPI AG

    Dr Madia Lozupone, Professor Daniele Manfredini

  34. The Relationship between Oral Health‐Related Quality of Life and Body Mass Index in an Older Population from Southern Italy: The Salus in Apulia Study

    Article • August 2023, MDPI AG

    Dr Madia Lozupone, Professor Daniele Manfredini

  35. Depressive and Biopsychosocial Frailty Phenotypes: Impact on Late-life Cognitive Disorders

    Article • Journal of Alzheimer’s Disease, August 2023, IOS Press

    Dr Madia Lozupone

  36. Clinical development of passive tau-based immunotherapeutics for treating primary and secondary tauopathies

    Article • Expert Opinion on Investigational Drugs, July 2023, Taylor & Francis

    Dr Madia Lozupone

  37. Exploring the Association of Burning Mouth Syndrome with Depressive and Anxiety Disorders in Middle-Aged and Older Adults: A Systematic Review

    Article • Journal of Personalized Medicine, June 2023, MDPI AG

    Dr Madia Lozupone

  38. Correction to: Dietary profiling of physical frailty in older age phenotypes using a machine learning approach: the Salus in Apulia Study

    Article • Zeitschrift für Ernährungswissenschaft, May 2023, Springer Science + Business Media

    Dr Madia Lozupone

  39. Late-Onset Depression but not Early-Onset Depression may Increase the Risk of All-Cause Mortality in Older Age: 8-Year Follow-Up of the Salus in Apulia Study

    Article • Journal of the American Medical Directors Association, May 2023, Elsevier

    Dr Madia Lozupone

  40. Processed foods and diet quality in pregnancy may affect child neurodevelopment disorders: a narrative review

    Article • Nutritional Neuroscience, April 2023, Taylor & Francis

    Dr Madia Lozupone

  41. The development of peptide- and oligonucleotide-based drugs to prevent the formation of abnormal tau in tauopathies

    Article • Expert Opinion on Drug Discovery, April 2023, Taylor & Francis

    Dr Madia Lozupone

  42. Associations of a biopsychosocial frailty phenotype with all-cause dementia, Alzheimer’s disease, vascular dementia, and other dementias: the Italian PRoject on the Epidemiology of Alzheimer’s disease (IPREA)

    Article • GeroScience, April 2023, Springer Science + Business Media

    Dr Madia Lozupone

  43. Effect of Physical Activity Intervention on Gait Speed by Frailty Condition: A Randomized Clinical Trial

    Article • Journal of the American Medical Directors Association, April 2023, Elsevier

    Dr Madia Lozupone

  44. Corrigendum: Dietary customs and social deprivation in an aging population from Southern Italy: A machine learning approach

    Article • Frontiers in Nutrition, March 2023, Frontiers

    Dr Madia Lozupone

  45. Corrigendum: Liver health and dementia in an Italian older population: Findings from the Salus in Apulia study

    Article • Frontiers in Aging Neuroscience, March 2023, Frontiers

    Dr Madia Lozupone

  46. Retinal Microvasculature and Neural Changes and Dietary Patterns in an Older Population in Southern Italy

    Article • International Journal of Environmental Research and Public Health, March 2023, MDPI AG

    Dr Madia Lozupone

  47. Effect of change of interleukin-6 over time on gait speed response: Results from the lifestyle interventions and independence for elders study

    Article • Mechanisms of Ageing and Development, March 2023, Elsevier

    Dr Madia Lozupone

  48. Serum levels of IL-6 are associated with cognitive impairment in the salus in apulia population-based study

    Article • Heliyon, March 2023, Elsevier

    Dr Madia Lozupone

  49. Ultra-processed food consumption and nutritional frailty in older age

    Article • GeroScience, February 2023, Springer Science + Business Media

    Dr Madia Lozupone

  50. Biopsychosocial frailty and mild cognitive impairment subtypes: Findings from the Italian project on the epidemiology of Alzheimer's disease (IPREA)

    Article • Alzheimer s & Dementia, February 2023, Wiley

    Dr Madia Lozupone

  51. Passive tau-based immunotherapy for tauopathies

    Article • January 2023, Elsevier

    Dr Madia Lozupone

  52. Temporomandibular Disorders as Contributors to Primary Headaches: A Systematic Review

    Article • Journal of Oral & Facial Pain and Headache, January 2023, MRE Press

    Dr Madia Lozupone

  53. Dietary profiling of physical frailty in older age phenotypes using a machine learning approach: the Salus in Apulia Study

    Article • Zeitschrift für Ernährungswissenschaft, December 2022, Springer Science + Business Media

    Dr Madia Lozupone

  54. Liver Fibrosis and Hearing Loss in an Older Mediterranean Population: Results from the Salus in Apulia Study

    Article • Journal of Clinical Medicine, December 2022, MDPI AG

    Dr Madia Lozupone

  55. Apolipoprotein E genotype, inflammatory biomarkers, and non-psychiatric multimorbidity contribute to the suicidal ideation phenotype in older age. The Salus in Apulia Study

    Article • Journal of Affective Disorders, December 2022, Elsevier

    Dr Madia Lozupone

  56. Clinical Indicators of Oral Frailty: A Domain-Specific Frailty Phenotype

    Article • Current Topics in Medicinal Chemistry, November 2022, Bentham Science Publishers

    Dr Madia Lozupone

  57. Temporomandibular Disorders as a Risk Factor for Suicidal Behavior: A Systematic Review

    Article • Journal of Personalized Medicine, October 2022, MDPI AG

    Dr Madia Lozupone

  58. Oral frailty indicators to target major adverse health-related outcomes in older age: a systematic review

    Article • GeroScience, October 2022, Springer Science + Business Media

    Dr Madia Lozupone, Professor Daniele Manfredini

  59. The challenges of anti-tau therapeutics in Alzheimer disease

    Article • Nature Reviews Neurology, August 2022, Springer Science + Business Media

    Dr Madia Lozupone

  60. Does the imbalance in the apolipoprotein E isoforms underlie the pathophysiological process of sporadic Alzheimer's disease?

    Article • Alzheimer s & Dementia, July 2022, Wiley

    Dr Madia Lozupone, Dr Bruno P Imbimbo

  61. ALZT-OP1: an experimental combination regimen for the treatment of Alzheimer’s disease

    Article • Expert Opinion on Investigational Drugs, June 2022, Taylor & Francis

    Dr Madia Lozupone

  62. Motoric Cognitive Risk Syndrome, Subtypes and 8-Year All-Cause Mortality in Aging Phenotypes: The Salus in Apulia Study

    Article • Brain Sciences, June 2022, MDPI AG

    Dr Madia Lozupone

  63. Motoric Cognitive Risk Syndrome, Subtypes and 8-year all-cause Mortality in Aging Phenotypes: The Salus in Apulia Study

    Article • April 2022, MDPI AG

    Dr Madia Lozupone

  64. Dietary Patterns Associated with Diabetes in an Older Population from Southern Italy Using an Unsupervised Learning Approach

    Article • Sensors, March 2022, MDPI AG

    Dr Madia Lozupone

  65. Role of Dietary Carotenoids in Frailty Syndrome: A Systematic Review

    Article • Biomedicines, March 2022, MDPI AG

    Dr Madia Lozupone

  66. Dietary Customs and Social Deprivation in an Aging Population From Southern Italy: A Machine Learning Approach

    Article • Frontiers in Nutrition, March 2022, Frontiers

    Dr Madia Lozupone

  67. Association of Neuroretinal Thinning and Microvascular Changes with Hypertension in an Older Population in Southern Italy

    Article • Journal of Clinical Medicine, February 2022, MDPI AG

    Dr Madia Lozupone

  68. Frailty and outcome after traumatic brain injury

    Article • The Lancet Neurology, February 2022, Elsevier

    Dr Madia Lozupone

  69. Processed meat consumption and the risk of incident late-onset depression: a 12-year follow-up of the Salus in Apulia Study

    Article • Age and Ageing, February 2022, Oxford University Press (OUP)

    Dr Madia Lozupone

  70. The diagnostic accuracy of late-life depression is influenced by subjective memory complaints and educational level in an older population in Southern Italy

    Article • Psychiatry Research, February 2022, Elsevier

    Dr Madia Lozupone

  71. Mediterranean Diet and Fatty Liver Risk in a Population of Overweight Older Italians: A Propensity Score-Matched Case-Cohort Study

    Article • Nutrients, January 2022, MDPI AG

    Dr Madia Lozupone

  72. Are apolipoprotein E fragments a promising new therapeutic target for Alzheimer’s disease?

    Article • Therapeutic Advances in Chronic Disease, January 2022, SAGE Publications

    Dr Bruno P Imbimbo, Dr Madia Lozupone

  73. Impact of Different Operational Definitions of Sarcopenia on Prevalence in a Population-Based Sample: The Salus in Apulia Study

    Article • International Journal of Environmental Research and Public Health, December 2021, MDPI AG

    Dr Madia Lozupone

  74. Liver Health and Dementia in an Italian Older Population: Findings From the Salus in Apulia Study

    Article • Frontiers in Aging Neuroscience, December 2021, Frontiers

    Dr Madia Lozupone

  75. Could Epigenetics Play a Role in Suicidal Behavior in Older Age?

    Article • Epigenomics, November 2021, Taylor & Francis

    Dr Madia Lozupone

  76. Liver Fibrosis and 8-Year All-Cause Mortality Trajectories in the Aging Cohort of the Salus in Apulia Study

    Article • Biomedicines, November 2021, MDPI AG

    Dr Madia Lozupone, MD Marco Castellana

  77. Beverages Consumption and Oral Health in the Aging Population: A Systematic Review

    Article • Frontiers in Nutrition, October 2021, Frontiers

    Dr Vittorio Dibello, Dr Madia Lozupone

  78. How many frailties exist? – Authors' reply

    Article • The Lancet Healthy Longevity, October 2021, Elsevier

    Dr Vittorio Dibello, Dr Madia Lozupone

  79. Associations between nutritional frailty and 8‐year all‐cause mortality in older adults: The Salus in Apulia Study

    Article • Journal of Internal Medicine, September 2021, Wiley

    Dr Vittorio Dibello, Vittorio Dibello, Dr Madia Lozupone

  80. COVID-19 clinical phenotypes and short-term outcomes: differences between the first and the second wave of pandemic in Italy

    Article • Expert Review of Respiratory Medicine, August 2021, Taylor & Francis

    Dr Madia Lozupone

  81. Liver frailty and all-cause mortality in the older participants of the Salus in Apulia Study

    Article • GeroScience, August 2021, Springer Science + Business Media

    Dr Madia Lozupone

  82. Oral frailty and its determinants in older age: a systematic review

    Article • The Lancet Healthy Longevity, August 2021, Elsevier

    Dr Vittorio Dibello, Dr Madia Lozupone

  83. Suicidal behaviour in older age: A systematic review of risk factors associated to suicide attempts and completed suicides

    Article • Neuroscience & Biobehavioral Reviews, August 2021, Elsevier

    Dr Madia Lozupone

  84. Association Between Central and Peripheral Age-Related Hearing Loss and Different Frailty Phenotypes in an Older Population in Southern Italy

    Article • JAMA Otolaryngology–Head & Neck Surgery, June 2021, American Medical Association (AMA)

    Dr Vittorio Dibello, Dr Madia Lozupone

  85. Physical and cognitive profiles in motoric cognitive risk syndrome in an older population from Southern Italy

    Article • European Journal of Neurology, May 2021, Wiley

    Dr Madia Lozupone

  86. Dietary Habits and Nutrient Intakes Are Associated to Age-Related Central Auditory Processing Disorder in a Cohort From Southern Italy

    Article • Frontiers in Aging Neuroscience, May 2021, Frontiers

    Dr Madia Lozupone

  87. Physical Frailty, Multimorbidity, and All-Cause Mortality in an Older Population From Southern Italy: Results from the Salus in Apulia Study

    Article • Journal of the American Medical Directors Association, March 2021, Elsevier

    Dr Madia Lozupone

  88. How gait influences frailty models and health‐related outcomes in clinical‐based and population‐based studies: a systematic review

    Article • Journal of Cachexia Sarcopenia and Muscle, February 2021, Wiley

    Dr Madia Lozupone

  89. Vitamin D in the development and progression of alzheimer’s disease: implications for clinical management

    Article • Expert Review of Neurotherapeutics, January 2021, Taylor & Francis

    Dr Vittorio Dibello, Dr Madia Lozupone

  90. Role of plant-based diet in late-life cognitive decline: results from the Salus in Apulia Study

    Article • Nutritional Neuroscience, January 2021, Taylor & Francis

    Dr Madia Lozupone

  91. Oral frailty and neurodegeneration in Alzheimer’s disease

    Article • Neural Regeneration Research, January 2021, Medknow

    Dr Vittorio Dibello, Dr Madia Lozupone, Professor Daniele Manfredini

  92. Nutritional domains in frailty tools: Working towards an operational definition of nutritional frailty

    Article • Ageing Research Reviews, December 2020, Elsevier

    Dr Madia Lozupone

  93. Late-life depression and its impact on rehabilitation after traumatic injuries

    Article • Aging Clinical and Experimental Research, November 2020, Springer Science + Business Media

    Dr Madia Lozupone

  94. Social Frailty in the COVID-19 Pandemic Era

    Article • Frontiers in Psychiatry, November 2020, Frontiers

    Dr Madia Lozupone

  95. A multidimensional frailty approach in predicting and preventing dementia

    Article • The Lancet Healthy Longevity, November 2020, Elsevier

    Dr Madia Lozupone

  96. Late-onset depression is associated to age-related central auditory processing disorder in an older population in Southern Italy

    Article • GeroScience, October 2020, Springer Science + Business Media

    Dr Madia Lozupone

  97. Retinal Vascular Density on Optical Coherence Tomography Angiography and Age-Related Central and Peripheral Hearing Loss in a Southern Italian Older Population

    Article • The Journals of Gerontology Series A, October 2020, Oxford University Press (OUP)

    Dr Madia Lozupone

  98. Pharmacological management of dementia with Lewy bodies with a focus on zonisamide for treating parkinsonism

    Article • Expert Opinion on Pharmacotherapy, October 2020, Taylor & Francis

    Dr Madia Lozupone, Dr Bruno P Imbimbo

  99. Age-related hearing loss and neuropathologic burden

    Article • Neurology, September 2020, Wolters Kluwer Health

    Dr Madia Lozupone

  100. The relationship between epigenetics and microbiota in neuropsychiatric diseases

    Article • Epigenomics, September 2020, Future Medicine

    Dr Vittorio Dibello, Dr Madia Lozupone

  101. Age-related hearing loss and speech perception disorder: the broken interface between healthcare professionals and older adults

    Article • European Geriatric Medicine, August 2020, Springer Science + Business Media

    Dr Madia Lozupone

  102. Discontinued disease-modifying therapies for Alzheimer’s disease: status and future perspectives

    Article • Expert Opinion on Investigational Drugs, July 2020, Taylor & Francis

    Dr Bruno P Imbimbo, Dr Madia Lozupone

  103. Anti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs

    Article • Expert Opinion on Emerging Drugs, July 2020, Taylor & Francis

    Dr Vittorio Dibello, Dr Madia Lozupone

  104. Can pharmacotherapy effectively reduce Alzheimer’s related agitation?

    Article • Expert Opinion on Pharmacotherapy, June 2020, Taylor & Francis

    Dr Madia Lozupone

  105. Age-Related Central Auditory Processing Disorder, MCI, and Dementia in an Older Population of Southern Italy

    Article • Otolaryngology, April 2020, SAGE Publications

    Dr Madia Lozupone

  106. Traditional Dietary Patterns and Risk of Mortality in a Longitudinal Cohort of the Salus in Apulia Study

    Article • Nutrients, April 2020, MDPI AG

    Francesco Panza, Dr Madia Lozupone

  107. The association of patient-reported symptoms and clinical and lung function parameters in patients with chronic obstructive pulmonary disease in stable phase

    Article • Expert Review of Respiratory Medicine, April 2020, Taylor & Francis

    Francesco Panza, Dr Madia Lozupone

  108. Social determinants of late-life depression epigenetics

    Article • Epigenomics, April 2020, Future Medicine

    Dr Madia Lozupone

  109. Development of disease-modifying drugs for frontotemporal dementia spectrum disorders

    Article • Nature Reviews Neurology, March 2020, Springer Science + Business Media

    Dr Bruno P Imbimbo, Francesco Panza, Dr Madia Lozupone

  110. Relationship between Inflammatory Food Consumption and Age-Related Hearing Loss in a Prospective Observational Cohort: Results from the Salus in Apulia Study

    Article • Nutrients, February 2020, MDPI AG

    MD Marco Castellana, Dr Madia Lozupone, Francesco Panza

  111. Corrigendum to “Nutritional interventions and cognitive-related outcomes in patients with late-life cognitive disorders: A systematic review” Neurosci. Biobehav. Rev. 95 (2018) 480–498

    Article • Neuroscience & Biobehavioral Reviews, January 2020, Elsevier

    Dr Madia Lozupone, Dr Vittorio Dibello

  112. The Challenge of Antidepressant Therapeutics in Alzheimer’s Disease

    Article • January 2020, Springer Science + Business Media

    Dr Madia Lozupone

  113. Liver fibrosis score, physical frailty, and the risk of dementia in older adults: The Italian Longitudinal Study on Aging

    Article • Alzheimer s & Dementia Translational Research & Clinical Interventions, January 2020, Wiley

    Dr Bruno P Imbimbo, Dr Madia Lozupone

  114. Do anti-amyloid-β drugs affect neuropsychiatric status in Alzheimer’s disease patients?

    Article • Ageing Research Reviews, November 2019, Elsevier

    Dr Madia Lozupone, Dr Bruno P Imbimbo

  115. Pharmacogenetics in the clinical analysis laboratory: clinical practice, research, and drug development pipeline

    Article • Expert Opinion on Drug Metabolism & Toxicology, September 2019, Taylor & Francis

    Dr Madia Lozupone

  116. Time to test antibacterial therapy in Alzheimer’s disease

    Article • Brain, August 2019, Oxford University Press (OUP)

    Dr Madia Lozupone, Dr Bruno P Imbimbo, Francesco Panza

  117. Episodic memory and learning rates in amyotrophic lateral sclerosis without dementia

    Article • Cortex, August 2019, Elsevier

    Dr Madia Lozupone

  118. Biopsychosocial frailty and the risk of incident dementia: The Italian longitudinal study on aging

    Article • Alzheimer s & Dementia, August 2019, Elsevier

    Dr Madia Lozupone

  119. The Age-Related Central Auditory Processing Disorder: Silent Impairment of the Cognitive Ear

    Article • Frontiers in Neuroscience, June 2019, Frontiers

    Dr Madia Lozupone

  120. Do BACE inhibitor failures in Alzheimer patients challenge the amyloid hypothesis of the disease?

    Article • Expert Review of Neurotherapeutics, May 2019, Taylor & Francis

    Dr Madia Lozupone, Dr Bruno P Imbimbo, Francesco Panza

  121. Disease-modifying therapies for tauopathies: agents in the pipeline

    Article • Expert Review of Neurotherapeutics, April 2019, Taylor & Francis

    Professor Francesco Panza, Dr Madia Lozupone, Professor GIANCARLO G LOGROSCINO, Dr Bruno P Imbimbo, Francesco Panza

  122. Promising therapies for the treatment of frontotemporal dementia clinical phenotypes: from symptomatic to disease-modifying drugs

    Article • Expert Opinion on Pharmacotherapy, April 2019, Taylor & Francis

    Professor GIANCARLO G LOGROSCINO, Dr Madia Lozupone, Vittorio Dibello, Dr Bruno P Imbimbo, Dr Vittorio Dibello

  123. Hydroxytryptamine transporter gene-linked polymorphic region (5HTTLPR) is associated with delusions in Alzheimer’s disease

    Article • Translational Neurodegeneration, February 2019, Springer Science + Business Media

    Dr Madia Lozupone, Francesco Panza

  124. Understanding frailty to predict and prevent dementia

    Article • The Lancet Neurology, February 2019, Elsevier

    Dr Madia Lozupone

  125. Amyloid-β immunotherapy for alzheimer disease: Is it now a long shot?

    Article • Annals of Neurology, January 2019, Wiley

    Dr Madia Lozupone, Dr Bruno P Imbimbo, Francesco Panza

  126. Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke

    Article • Drugs, January 2019, Springer Science + Business Media

    Dr Madia Lozupone

  127. A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease

    Article • Nature Reviews Neurology, January 2019, Springer Science + Business Media

    Dr Madia Lozupone, Dr Bruno P Imbimbo, Francesco Panza

  128. Are antibodies directed against amyloid-β (Aβ) oligomers the last call for the Aβ hypothesis of Alzheimer's disease?

    Article • Immunotherapy, January 2019, Future Medicine

    Dr Madia Lozupone, Dr Bruno P Imbimbo, Dr Vittorio Dibello

  129. The Role of Biomarkers in Psychiatry

    Article • January 2019, Springer Science + Business Media

    Dr Madia Lozupone

  130. Nutritional interventions and cognitive-related outcomes in patients with late-life cognitive disorders: A systematic review

    Article • Neuroscience & Biobehavioral Reviews, December 2018, Elsevier

    Dr Madia Lozupone, Dr Vittorio Dibello

  131. Sensorial frailty: age-related hearing loss and the risk of cognitive impairment and dementia in later life

    Article • Therapeutic Advances in Chronic Disease, November 2018, SAGE Publications

    Professor Francesco Panza, Dr Madia Lozupone, Francesco Panza, Dr Vittorio Dibello

  132. BACE inhibitors in clinical development for the treatment of Alzheimer’s disease

    Article • Expert Review of Neurotherapeutics, October 2018, Taylor & Francis

    Dr Madia Lozupone, Vittorio Dibello, Professor GIANCARLO G LOGROSCINO, Dr Vittorio Dibello, Dr Bruno P Imbimbo, Francesco Panza

  133. Social Dysfunction in Older Age and Relationships with Cognition, Depression, and Apathy: The GreatAGE Study

    Article • Journal of Alzheimer’s Disease, September 2018, IOS Press

    Francesco Panza, Dr Madia Lozupone, Dr Bruno P Imbimbo

  134. CYP2D6 genotypes in revolving door patients with bipolar disorders

    Article • Medicine, September 2018, Wolters Kluwer Health

    Dr Madia Lozupone

  135. Nutritional Intervention as a Preventive Approach for Cognitive-Related Outcomes in Cognitively Healthy Older Adults: A Systematic Review

    Article • Journal of Alzheimer’s Disease, June 2018, IOS Press

    Francesco Panza, Dr Madia Lozupone, Dr Vittorio Dibello

  136. Pharmacotherapy for the treatment of depression in patients with alzheimer’s disease: a treatment-resistant depressive disorder

    Article • Expert Opinion on Pharmacotherapy, May 2018, Taylor & Francis

    Prof Nicola Quaranta, Dr Madia Lozupone, Vittorio Dibello, Dr Vittorio Dibello

  137. Different Cognitive Frailty Models and Health- and Cognitive-related Outcomes in Older Age: From Epidemiology to Prevention

    Article • Journal of Alzheimer’s Disease, March 2018, IOS Press

    Dr Madia Lozupone, Dr Vittorio Dibello

  138. Executive Dysfunction Detected with the Frontal Assessment Battery in Alzheimer’s Disease Versus Vascular Dementia

    Article • Journal of Alzheimer’s Disease, February 2018, IOS Press

    Francesco Panza, Dr Madia Lozupone

  139. Biopsychosocial Frailty and the Risk of Incident Dementia. The Italian Longitudinal Study of Aging

    Article • SSRN Electronic Journal, January 2018, Elsevier

    Dr Madia Lozupone

  140. Comprehensive Geriatric Assessment in Long-Term Care and Nursing Homes

    Article • December 2017, Springer Science + Business Media

    Dr Madia Lozupone

  141. Additive Role of a Potentially Reversible Cognitive Frailty Model and Inflammatory State on the Risk of Disability: The Italian Longitudinal Study on Aging

    Article • American Journal of Geriatric Psychiatry, November 2017, Elsevier

    Dr Madia Lozupone, Francesco Panza

  142. The potential of solanezumab and gantenerumab to prevent Alzheimer’s disease in people with inherited mutations that cause its early onset

    Article • Expert Opinion on Biological Therapy, October 2017, Taylor & Francis

    Dr Madia Lozupone, Dr Bruno P Imbimbo, Francesco Panza, Dr Vittorio Dibello

  143. Psychotropic drugs and CYP2D6 in late-life psychiatric and neurological disorders. What do we know?

    Article • Expert Opinion on Drug Safety, October 2017, Taylor & Francis

    Dr Madia Lozupone, Francesco Panza

  144. Cognitive frailty: a potential target for secondary prevention of dementia

    Article • Expert Opinion on Drug Metabolism & Toxicology, September 2017, Taylor & Francis

    Dr Madia Lozupone, Francesco Panza

  145. Innovative biomarkers in psychiatric disorders: a major clinical challenge in psychiatry

    Article • Expert Review of Proteomics, September 2017, Taylor & Francis

    Dr Madia Lozupone, Francesco Panza

  146. Relationships of Dietary Patterns, Foods, and Micro- and Macronutrients with Alzheimer’s Disease and Late-Life Cognitive Disorders: A Systematic Review

    Article • Journal of Alzheimer’s Disease, July 2017, IOS Press

    Francesco Panza, Dr Madia Lozupone, Dr Bruno P Imbimbo

  147. Midlife Metabolic Profile and the Risk of Late-Life Cognitive Decline

    Article • Journal of Alzheimer’s Disease, July 2017, IOS Press

    Professor GIANCARLO G LOGROSCINO, Francesco Panza, Dr Madia Lozupone, Dr Bruno P Imbimbo

  148. An Old Challenge with New Promises: A Systematic Review on Comprehensive Geriatric Assessment in Long-term Care Facilities

    Article • Rejuvenation Research, June 2017, Mary Ann Liebert Inc

    Francesco Panza, Dr Madia Lozupone, Dr Vittorio Dibello

  149. Role of CLU, PICALM, and TNK1 Genotypes in Aging With and Without Alzheimer’s Disease

    Article • Molecular Neurobiology, June 2017, Springer Science + Business Media

    Francesco Panza, Dr Madia Lozupone

  150. Emerging biomarkers and screening for cognitive frailty

    Article • Aging Clinical and Experimental Research, March 2017, Springer Science + Business Media

    Francesco Panza, Dr Madia Lozupone

  151. Genetics of tailored medicine: Focus on CNS drugs

    Article • Microchemical Journal, February 2017, Elsevier

    Francesco Panza, Dr Madia Lozupone

  152. Reversible Cognitive Frailty, Dementia, and All-Cause Mortality. The Italian Longitudinal Study on Aging

    Article • Journal of the American Medical Directors Association, January 2017, Elsevier

    Francesco Panza, Dr Madia Lozupone, Dr Bruno P Imbimbo

  153. Bipolar Disorder and Frontotemporal Dementia: An Intriguing Association

    Article • Journal of Alzheimer’s Disease, December 2016, IOS Press

    Francesco Panza, Dr Madia Lozupone, Dr Bruno P Imbimbo

  154. Pharmacogenetics of neurological and psychiatric diseases at older age: has the time come?

    Article • Expert Opinion on Drug Metabolism & Toxicology, October 2016, Taylor & Francis

    Dr Madia Lozupone, Francesco Panza

  155. Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer’s disease patients

    Article • Expert Opinion on Emerging Drugs, October 2016, Taylor & Francis

    Dr Madia Lozupone, Dr Bruno P Imbimbo, Francesco Panza

  156. The pharmacogenetic road to avoid adverse drug reactions and therapeutic failures in revolving door patients with psychiatric illnesses: focus on the CYP2D6 isoenzymes

    Article • Expert Review of Precision Medicine and Drug Development, September 2016, Taylor & Francis

    Dr Madia Lozupone

  157. Tau-based therapeutics for Alzheimer’s disease: active and passive immunotherapy

    Article • Immunotherapy, September 2016, Future Medicine

    Professor Francesco Panza, Francesco Panza, Dr Madia Lozupone, Dr Bruno P Imbimbo

  158. Psychiatry meets pharmacogenetics for the treatment of revolving door patients with psychiatric disorders

    Article • Expert Review of Neurotherapeutics, July 2016, Taylor & Francis

    Francesco Panza, Dr Madia Lozupone

  159. High doses of incobotulinumtoxinA for the treatment of post-stroke spasticity: are they safe and effective?

    Article • Expert Opinion on Drug Metabolism & Toxicology, June 2016, Taylor & Francis

    Francesco Panza, Dr Madia Lozupone

  160. Tau-directed approaches for the treatment of Alzheimer’s disease: focus on leuco-methylthioninium

    Article • Expert Review of Neurotherapeutics, February 2016, Informa Healthcare

    Francesco Panza, Dr Madia Lozupone, Dr Bruno P Imbimbo

  161. Tau aggregation inhibitors: the future of Alzheimer’s pharmacotherapy?

    Article • Expert Opinion on Pharmacotherapy, February 2016, Informa Healthcare

    Francesco Panza, Dr Madia Lozupone, Dr Bruno P Imbimbo

  162. Klotho Gene and Selective Serotonin Reuptake Inhibitors: Response to Treatment in Late-Life Major Depressive Disorder

    Article • Molecular Neurobiology, February 2016, Springer Science + Business Media

    Dr Madia Lozupone, Francesco Panza

  163. Examination of level of knowledge in Italian general practitioners attending an education session on diagnosis and management of the early stage of Alzheimer's disease: pass or fail?

    Article • International Psychogeriatrics, January 2016, Cambridge University Press

    Dr Madia Lozupone, Dr Bruno P Imbimbo, Francesco Panza

  164. Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer’s Disease

    Article • BioMed Research International, January 2016, Hindawi Publishing Corporation

    Francesco Panza, Dr Madia Lozupone, Dr Bruno P Imbimbo

  165. Alternative pharmacological treatment options for agitation in Alzheimer’s disease

    Article • Geriatric Care, November 2015, PAGEPress Publications

    Francesco Panza, Dr Madia Lozupone

  166. Progresses in treating agitation: a major clinical challenge in Alzheimer’s disease

    Article • Expert Opinion on Pharmacotherapy, September 2015, Informa Healthcare

    Francesco Panza, Dr Madia Lozupone, Dr Bruno P Imbimbo

  167. Psychopathological profile and health-related quality of life (HRQOL) in patients with hepatocellular carcinoma (HCC) and cirrhosis

    Article • Clinical and Experimental Medicine, December 2013, Springer Science + Business Media

    Dr Madia Lozupone

  168. Metabolic Syndrome: Differences between Psychiatric and Internal Medicine Patients

    Article • The International Journal of Psychiatry in Medicine, April 2013, SAGE Publications

    Dr Madia Lozupone

  169. Genetically Determined Measures of Striatal D2 Signaling Predict Prefrontal Activity during Working Memory Performance

    Article • PLOS One, February 2010, PLOS

    Dr Madia Lozupone